Jung Jin Seo, Celltrion founder (Celltrion)

Ko­re­a's Cell­tri­on in­vests $453M in­to new man­u­fac­tur­ing plant, re­search cen­ter

Less than a year af­ter blue­print­ing a $514 mil­lion bi­o­log­ics plant in Chi­na, Cell­tri­on is pour­ing an­oth­er $453 mil­lion in­to build­ing a new re­search cen­ter and man­u­fac­tur­ing fa­cil­i­ty in its home city of In­cheon, Ko­rea.

Like Sam­sung Bi­o­log­ics, which is plan­ning to con­struct a $2 bil­lion “su­per plant,” Cell­tri­on said it’s look­ing to “proac­tive­ly re­spond to the rapid­ly in­creas­ing glob­al bio­phar­ma­ceu­ti­cal de­mand, and fo­cus our ca­pa­bil­i­ties on more flex­i­ble and ef­fi­cient bio­phar­ma­ceu­ti­cal re­search in the fu­ture.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.